Fertility and pregnancy outcome in women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency
The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Low pregnancy rate has been reported in women with congenital adrenal hyperplasia (CAH) and little information on pregnancy and children is known. METHODS: In a Swedish study, 62 adult women with CAH, aged 18-63 years, and 62 age-matched controls were followed-up. Medical records, including those concerning pregnancies and deliveries, were examined and the 21-hydroxylase genotype of patients was noted. All women answered a questionnaire concerning sexual and reproductive health including health of the children. RESULTS: Pregnancy and delivery rates were significantly lower in women with CAH (P < 0.001, P < 0.0056, respectively), and the severity of the 21-hydroxylase-mutation correlated with the reduced number of children born. More women with salt-wasting CAH were single and had not attempted pregnancy. Pregnancies were normal except for a significantly increased incidence of gestational diabetes in CAH patients (P < 0.0024). The children had normal birthweight and no malformations were observed. A later follow-up of the children showed a normal intellectual and social development. The sex ratio of the offspring differed significantly, with 25% boys in the CAH group compared with 56% among controls (P < 0.016). CAH women had more gynaecological morbidity during menopause. CONCLUSIONS: Pregnancy and delivery rates are reduced in women with CAH mainly due to psychosocial reasons. The outcome of children did not differ from controls. The unexpected sex ratio in children born to mothers with CAH warrants further research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Women with CAH may be at increased risk for gestational diabetes (257, 260).”
From Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society* Clinical Practice Guideline (2018) · cites this paper as [257]
The cited source says what the claim attributes to it.
In the citing paper
“Several studies have shown that, for a variety of reasons, only a minority of women with classic CAH try to conceive (225, 257).”
From Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society* Clinical Practice Guideline (2018) · cites this paper as [257]
In the citing paper
“Caesarean section is the most common method of delivery due to the high prevalence of previous vaginal surgery and cephalopelvic disproportion, although vaginal delivery has been reported in 16% to 42% of women, nearly all of whom had a non-salt-wasting phenotype (225, 257).”
From Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society* Clinical Practice Guideline (2018) · cites this paper as [257]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2002) · Hormone Research in Paediatrics · doi:10.1159/000065490 · Cited by 458
Wedell, A. (1994) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.78.5.1145 · Cited by 370 · cited 1×
“All three types are highly correlated with the spectrum of 21-hydroxylase mutations and to the severity of the disease (Wedell et al., 1994; Pinto et al., 2003).”
BackgroundMulaikal, R. M., Migeon, C. J., & Rock, J. A. (1987) · New England Journal of Medicine · doi:10.1056/nejm198701223160402 · Cited by 361
Nordenskjöld, A., Holmdahl, G., Frisén, L., Falhammar, H., Filipsson, H., Thorén, M., Janson, P. O., & Hagenfeldt, K. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0556 · Cited by 205 · cited 5×
“A majority of the CAH women had undergone genital surgery and many were dissatisfied with their genitals (Nordenskjöld et al., 2008).”
BackgroundMethodSelf-citationGastaud, F., Bouvattier, C., Duranteau, L., Brauner, R., Thibaud, E., Kutten, F., & Bougnères, P. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1757 · Cited by 192
Falhammar, H., Filipsson, H., Holmdahl, G., Janson, P.-O., Nordenskjöld, A., Hagenfeldt, K., & Thorén, M. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1350 · Cited by 167 · cited 5×
“She discontinued metformin in early pregnancy and developed mild gestational diabetes during the last part of the pregnancy and was treated with insulin (Falhammar et al., 2007c).”
BackgroundMethodFractures and bone mineral density in adult women with 21-hydroxylase deficiency
Falhammar, H., Filipsson, H., Holmdahl, G., Janson, P.-O., Nordenskjöld, A., Hagenfeldt, K., & Thorén, M. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0744 · Cited by 151 · cited 5×
“She discontinued metformin in early pregnancy and developed mild gestational diabetes during the last part of the pregnancy and was treated with insulin (Falhammar et al., 2007c).”
BackgroundMethodSelf-citationKrone, N., Wachter, I., Stefanidou, M., Roscher, A. A., & Schwarz, H. P. (2001) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2001.01359.x · Cited by 135 · cited 9×
“In comparison, in the data presented by Krone et al. (2001), the doses were increased in one-third of the pregnancies.”
BackgroundResultInfluentialWhat Causes Low Rates of Child-Bearing in Congenital Adrenal Hyperplasia?
Meyer-Bahlburg, H. F. L. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.6.5718 · Cited by 110
Long-Term Outcome of Patients with Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency
Bachelot, A., Plu-Bureau, G., Thibaud, E., Laborde, K., Pinto, G., Samara, D., Nihoul-Fékété, C., Kuttenn, F., Polak, M., & Touraine, P. (2007) · Hormone Research in Paediatrics · doi:10.1159/000098017 · Cited by 106
Cited by
Speiser, P. W., Azziz, R., Baskin, L. S., Ghizzoni, L., Hensle, T. W., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Montori, V. M., Oberfield, S. E., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2631 · Cited by 1,468
Speiser, P. W., Arlt, W., Auchus, R. J., Baskin, L. S., Conway, G. S., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Murad, M. H., Oberfield, S. E., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01865 · Cited by 1,234
Congenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management
Claahsen - van der Grinten, H. L., Speiser, P. W., Ahmed, S. F., Arlt, W., Auchus, R. J., Falhammar, H., Flück, C. E., Guasti, L., Huebner, A., Kortmann, B. B. M., et al. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab016 · Cited by 556
Health status of adults with congenital adrenal hyperplasia: a cohort study of 203 patients
Arlt, W., Willis, D. S., Wild, S. H., Krone, N., Doherty, E. J., Hahner, S., Han, T. S., Carroll, P. V., Conway, G. S., Rees, D. A., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0917 · Cited by 506
Frisén, L., Nordenström, A., Falhammar, H., Filipsson, H., Holmdahl, G., Janson, P. O., Thorén, M., Hagenfeldt, K., Möller, A., & Nordenskjöld, A. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0636 · Cited by 276
Self-citationCongenital adrenal hyperplasia
Auer, M. K., Nordenström, A., Lajic, S., & Reisch, N. (2023) · The Lancet · doi:10.1016/s0140-6736(22)01330-7 · Cited by 215
Fertility in women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency
Bidet, M., Bellanné-Chantelot, C., Galand-Portier, M.-B., Golmard, J.-L., Tardy, V., Morel, Y., Clauin, S., Coussieu, C., Boudou, P., Mowzowicz, I., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1383 · Cited by 204
Falhammar, H., Frisén, L., Hirschberg, A. L., Norrby, C., Almqvist, C., Nordenskjöld, A., & Nordenström, A. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2093 · Cited by 204
Self-citationEndocrine disorders & female infertility
Unuane, D., Tournaye, H., Velkeniers, B., & Poppe, K. (2011) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2011.08.001 · Cited by 186
Congenital Adrenal Hyperplasia
Witchel, S. F. (2017) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2017.04.001 · Cited by 184
Falhammar, H., Nyström, H. F., Ekström, U., Granberg, S., Wedell, A., & Thorén, M. (2012) · European Journal of Endocrinology · doi:10.1530/eje-11-0828 · Cited by 170
Self-citationNordenström, A., Frisén, L., Falhammar, H., Filipsson, H., Holmdahl, G., Janson, P. O., Thorén, M., Hagenfeldt, K., & Nordenskjöld, A. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2639 · Cited by 161
Nordenström, A., & Falhammar, H. (2019) · European Journal of Endocrinology · doi:10.1530/eje-18-0712 · Cited by 158
Self-citationCongenital Adrenal Hyperplasia
Witchel, S. F., & Azziz, R. (2011) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2010.10.001 · Cited by 159
Clinical perspectives in congenital adrenal hyperplasia due to 11β-hydroxylase deficiency
Bulsari, K., & Falhammar, H. (2016) · Endocrine · doi:10.1007/s12020-016-1189-x · Cited by 149
Krone, N., Rose, I. T., Willis, D. S., Hodson, J., Wild, S. H., Doherty, E. J., Hahner, S., Parajes, S., Stimson, R. H., Han, T. S., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3343 · Cited by 119
“Most women with null and A mutations in our study had never tried to have children, which is a similar finding to reports from Sweden (25).”
MethodResultFalhammar, H., & Nordenström, A. (2015) · Endocrine · doi:10.1007/s12020-015-0656-0 · Cited by 127
Self-citationVerma, S., VanRyzin, C., Sinaii, N., Kim, M. S., Nieman, L. K., Ravindran, S., Calis, K. A., Arlt, W., Ross, R. J., & Merke, D. P. (2010) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2009.03636.x · Cited by 126
Strandqvist, A., Falhammar, H., Lichtenstein, P., Hirschberg, A. L., Wedell, A., Norrby, C., Nordenskjöld, A., Frisén, L., & Nordenström, A. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3326 · Cited by 111
Health Problems in Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency
Reisch, N., Arlt, W., & Krone, N. (2011) · Hormone Research in Paediatrics · doi:10.1159/000327794 · Cited by 106
Clinical outcomes in the management of congenital adrenal hyperplasia
Falhammar, H., & Thorén, M. (2012) · Endocrine · doi:10.1007/s12020-011-9591-x · Cited by 106
Self-citationFertility in patients with congenital adrenal hyperplasia
Reichman, D. E., White, P. C., New, M. I., & Rosenwaks, Z. (2013) · Fertility and Sterility · doi:10.1016/j.fertnstert.2013.11.002 · Cited by 112
Falhammar, H., Filipsson Nyström, H., Wedell, A., & Thorén, M. (2011) · European Journal of Endocrinology · doi:10.1530/eje-10-0877 · Cited by 103
Self-citationFemale infertility of endocrine origin
Weiss, R. V., & Clapauch, R. (2014) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/0004-2730000003021 · Cited by 119
Gestational Hyperandrogenism in Developmental Programming
Hakim, C., Padmanabhan, V., & Vyas, A. K. (2017) · Endocrinology · doi:10.1210/en.2016-1801 · Cited by 97
Lee, P. A., Schober, J. M., Nordenström, A., Hoebeke, P. B., Houk, C. P., Looijenga, L. H. J., Manzoni, G., Reiner, W. G., & Woodhouse, C. R. J. (2012) · Journal of Pediatric Urology · doi:10.1016/j.jpurol.2012.10.017 · Cited by 102
Nermoen, I., Husebye, E. S., Svartberg, J., & Løvås, K. (2010) · European Journal of Endocrinology · doi:10.1530/eje-10-0284 · Cited by 89
Disorders of Sex Development: Classification, Review, and Impact on Fertility
Acién, P., & Acién, M. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9113555 · Cited by 99
“women, infertility can occur as a result of anovulation, menstrual irregularities, thickening of the cervical mucus, and anatomical factors [39], but there are also other important psychosocial factors that affect fertility in people with CAH and that may include the lack of a stable relationship or a smaller number o…”
BackgroundRecommendations for treatment of nonclassic congenital adrenal hyperplasia (NCCAH): An update
Trapp, C. M., & Oberfield, S. E. (2012) · Steroids · doi:10.1016/j.steroids.2011.12.009 · Cited by 81
“Of interest in this small study, an unexplained decrease in male offspring was noted in patients with CAH [51].”
BackgroundBiochemical and genetic diagnosis of 21-hydroxylase deficiency
Falhammar, H., Wedell, A., & Nordenström, A. (2015) · Endocrine · doi:10.1007/s12020-015-0731-6 · Cited by 80
Self-citationAl Alawi, A. M., Nordenström, A., & Falhammar, H. (2019) · Endocrine · doi:10.1007/s12020-018-01835-3 · Cited by 77
Self-citationHealth-related quality of life in children with disorders of sex development (DSD)
Jürgensen, M., Lux, A., Wien, S. B., Kleinemeier, E., Hiort, O., & Thyen, U. (2014) · European Journal of Pediatrics · doi:10.1007/s00431-014-2264-z · Cited by 96
MANAGEMENT OF ENDOCRINE DISEASE: Gonadal dysfunction in congenital adrenal hyperplasia
Claahsen-van der Grinten, H. L., Stikkelbroeck, N., Falhammar, H., & Reisch, N. (2021) · European Journal of Endocrinology · doi:10.1530/eje-20-1093 · Cited by 72
Self-citationLong-Term Outcome of Disorders of Sex Development
Warne, G. L. (2008) · Sexual Development · doi:10.1159/000152043 · Cited by 77
“…in control groups [Kuhnle et al., 1993, 1995; May et al., 1996], have greater degrees of pain and discomfort associated with penetrative intercourse [Warne et al., 2005a], are less fertile [Hagenfeldt et al., 2008], and have an increased risk of gestational diabetes [Falhammar et al., 2007].”
BackgroundHirschberg, A. L., Gidlöf, S., Falhammar, H., Frisén, L., Almqvist, C., Nordenskjöld, A., & Nordenström, A. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa801 · Cited by 65
Self-citationDisorders of sex development: Summaries of long-term outcome studies
Schober, J. M., Nordenström, A., Hoebeke, P. B., Lee, P. A., Houk, C. P., Looijenga, L. H. J., Manzoni, G., Reiner, W. G., & Woodhouse, C. R. J. (2012) · Journal of Pediatric Urology · doi:10.1016/j.jpurol.2012.08.005 · Cited by 72
“However, the fertility was lower in the more severe genotype groups, underscoring the importance of relating the fertility results to disease severity, or molecular diagnosis [31].”
BackgroundFertility and sexuality issues in congenital lifelong urology patients: male aspects
Spinoit, A., Waterschoot, M., Sinatti, C., Abbas, T. O., Callens, N., Cools, M., Hamid, R., Hanna, M. K., Joshi, P. M., Misseri, R., et al. (2020) · World Journal of Urology · doi:10.1007/s00345-020-03121-2 · Cited by 65
Management of CAH during pregnancy: optimizing outcomes
Witchel, S. F. (2012) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0b013e32835a1a2e · Cited by 62
Falhammar, H., Frisén, L., Norrby, C., Almqvist, C., Hirschberg, A. L., Nordenskjöld, A., & Nordenström, A. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01139 · Cited by 60
Self-citationBilateral Adrenalectomy in Congenital Adrenal Hyperplasia: A Systematic Review and Meta-Analysis
MacKay, D., Nordenström, A., & Falhammar, H. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00217 · Cited by 59
Self-citationBachelot, A., Grouthier, V., Courtillot, C., Dulon, J., & Touraine, P. (2017) · European Journal of Endocrinology · doi:10.1530/eje-16-0888 · Cited by 57
Gomes, N. L., Chetty, T., Jørgensen, A., & Mitchell, R. T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072282 · Cited by 63
Congenital adrenal hyperplasia – pharmacologic interventions from the prenatal phase to adulthood
Claahsen-van der Grinten, H. L., Stikkelbroeck, N. M. M. L., Otten, B. J., & Hermus, A. R. M. M. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.05.004 · Cited by 53
Adrenal disorders in pregnancy
Monticone, S., Auchus, R. J., & Rainey, W. E. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2012.155 · Cited by 58
Sexual Orientation in Individuals With Congenital Adrenal Hyperplasia: A Systematic Review
Daae, E., Feragen, K. B., Waehre, A., Nermoen, I., & Falhammar, H. (2020) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2020.00038 · Cited by 50
Congenital Adrenal Hyperplasia: Classification of Studies Employing Psychological Endpoints
Stout, S. A., Litvak, M., Robbins, N. M., & Sandberg, D. E. (2010) · International Journal of Pediatric Endocrinology · doi:10.1155/2010/191520 · Cited by 48
Psychoendocrinology of Congenital Adrenal Hyperplasia
Meyer-Bahlburg, H. F. L. (2014) · Genetic Steroid Disorders · doi:10.1016/b978-0-12-416006-4.00023-5 · Cited by 48
Speiser, P. W., Azziz, R., Baskin, L. S., Ghizzoni, L., Hensle, T. W., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Montori, V. M., Oberfield, S. E., et al. (2010) · International Journal of Pediatric Endocrinology · doi:10.1155/2010/494173 · Cited by 45
Insulinooporność w chorobach endokrynnych — sposoby terapii
Rogowicz‐Frontczak, A., Majchrzak, A., & Zozulińska‐Ziółkiewicz, D. (2017) · Endokrynologia Polska · doi:10.5603/ep.2017.0026 · Cited by 56
Bothou, C., Anand, G., Li, D., Kienitz, T., Seejore, K., Simeoli, C., Ebbehoj, A., Ward, E. G., Paragliola, R. M., Ferrigno, R., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa266 · Cited by 44
“the rate of spontaneous abortions were not higher in comparison to a control population (17).”
ResultSelf-citationNordenström, A. (2011) · Current Opinion in Pediatrics · doi:10.1097/mop.0b013e32834810a4 · Cited by 42
Long-Term Outcomes of Congenital Adrenal Hyperplasia
Nordenström, A., Lajić, S., & Falhammar, H. (2022) · Endocrinology and Metabolism · doi:10.3803/enm.2022.1528 · Cited by 49
“The age of pubertal onset and menarche in girls with CAH is similar to controls [35,86].”
InfluentialFalhammar, H., Nyström, H. F., & Thorén, M. C. (2014) · Endocrine · doi:10.1007/s12020-013-0161-2 · Cited by 43
Infertility and Reproductive Function in Patients with Congenital Adrenal Hyperplasia
Lekarev, O., Lin-Su, K., & Vogiatzi, M. G. (2015) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2015.07.009 · Cited by 38
The management of congenital adrenal hyperplasia during preconception, pregnancy, and postpartum
Maher, J. Y., Gomez‐Lobo, V., & Merke, D. P. (2022) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-022-09770-5 · Cited by 48
Reisch, N. (2019) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-0820-2085 · Cited by 36
“The expression of these factors is related to the severity of the steroid 21-hydroxylase mutation so that child rate is particularly poor in the salt-wasting group [60, 61].”
BackgroundPregnancy in Congenital Adrenal Hyperplasia
Reisch, N. (2019) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2019.05.011 · Cited by 36
FALHAMMAR, H., FILIPSSON, H., HOLMDAHL, G., JANSON, P.-O., NORDENSKJÖLD, A., HAGENFELDT, K., & THORÉN, M. (2009) · Endocrine Journal · doi:10.1507/endocrj.k08e-312 · Cited by 35
Fertility and sexuality issues in congenital lifelong urology patients: female aspects
Win, G. D., Dautricourt, S., Deans, R., Hamid, R., Hanna, M. K., Khavari, R., Misseri, R., Mueller, M. G., Roth, J. D., & Spinoit, A. (2020) · World Journal of Urology · doi:10.1007/s00345-020-03461-z · Cited by 34
Early prenatal androgenization results in diminished ovarian reserve in adult female rhesus monkeys
Dumesic, D. A., Patankar, M. S., Barnett, D. K., Lesnick, T. G., Hutcherson, B. A., & Abbott, D. H. (2009) · Human Reproduction · doi:10.1093/humrep/dep324 · Cited by 33
“tion (Hagenfeldt et al., 2008).”
Mooij, C. F., Webb, E. A., Claahsen van der Grinten, H. L., & Krone, N. (2017) · Archives of Disease in Childhood · doi:10.1136/archdischild-2016-311910 · Cited by 31
Sarafoglou, K., Merke, D. P., Reisch, N., der Grinten, H. L. C., Falhammar, H., & Auchus, R. J. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad134 · Cited by 35
Growth and Reproductive Outcomes in Congenital Adrenal Hyperplasia
Nebesio, T. D., & Eugster, E. A. (2010) · International Journal of Pediatric Endocrinology · doi:10.1155/2010/298937 · Cited by 34
“Women with the most severe, salt-wasting forms have the lowest fertility rates [82, 86].”
BackgroundCongenital adrenal hyperplasia
Hughes, I. A. (2005) · Oxford University Press eBooks · doi:10.1016/j.mpmed.2009.05.007 · Cited by 28
Kocova, M., Anastasovska, V., & Falhammar, H. (2020) · Endocrine · doi:10.1007/s12020-020-02323-3 · Cited by 24
Self-citationHuang, G., Aroner, S. A., Bay, C. P., Gilman, S. E., Ghassabian, A., Loucks, E. B., Buka, S. L., Handa, R. J., Lasley, B. L., Bhasin, S., et al. (2021) · Journal of Endocrinological Investigation · doi:10.1007/s40618-020-01385-4 · Cited by 24
Long‐term health consequences of congenital adrenal hyperplasia
Pofi, R., Ji, X., Krone, N. P., & Tomlinson, J. (2023) · Clinical Endocrinology · doi:10.1111/cen.14967 · Cited by 30
“22,23 In addition to hormonal imbalances, female patients with CAH can also suffer with anatomical and psychological issues alongside a reduced interest in pursuing parenthood.”
Cardiometabolic Aspects of Congenital Adrenal Hyperplasia
Krysiak, R. G., der Grinten, H. L. C., Reisch, N., Touraine, P. A., & Falhammar, H. (2024) · Endocrine Reviews · doi:10.1210/endrev/bnae026 · Cited by 26
Badeghiesh, A. M., Ismail, S., Baghlaf, H. A., Suarthana, E., & Dahan, M. H. (2020) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2020.08.036 · Cited by 25
Mnif, M. F., Kamoun, M., Kacem, F. H., Mnif, F., Charfi, N., Naceur, B. B., Rekik, N., & Abid, M. (2013) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.117196 · Cited by 22
“Several factors have been suggested to contribute to this low fertility.[2-5]”
BackgroundEndocrine factors associated with infertility in women: an updated review
Concepción‐Zavaleta, M. J., Arroyo, J., Aldave, J. E. Q., Durand‐Vásquez, M. D. C., Ildefonso-Najarro, S. P., Rafael-Robles, L. D. P., Urteaga, L. A. C., Osorio, E. R. G., Suárez-Rojas, J., & Paz‐Ibarra, J. (2023) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2023.2256405 · Cited by 34
“Furthermore, the accumulation of 17-hydroxyprogesterone is associated with alterations in endometrial maturation and possibly implantation [79].”
BackgroundLajić, S., Karlsson, L., Zetterström, R. H., Falhammar, H., & Nordenström, A. (2020) · International Journal of Neonatal Screening · doi:10.3390/ijns6030068 · Cited by 25
“However, decreased sexual activity, higher sexual distress, higher prevalence of homosexuality or bisexuality, and disinterest in pursuing motherhood most likely play a role in the decreased fertility rate [24,25].”
BackgroundRussian clinical practice guidelines «congenital adrenal hyperplasia»
Mokrysheva, N. G., Mel'nichenko, G. A., Adamyan, L. V., Troshina, E. A., Молашенко, Н. В., Игоревна, С. А., Uvarova, E. V., Esayan, E. R. M., Andreeva, E. N., Ужегова, Ж. А., et al. (2021) · Obesity and metabolism · doi:10.14341/omet12787 · Cited by 30
Nygren, U., Nyström, H. F., Falhammar, H., Hagenfeldt, K., Nordenskjöld, A., & Södersten, M. (2013) · Clinical Endocrinology · doi:10.1111/cen.12226 · Cited by 21
Guo, X., Zhang, Y., Yu, Y., Zhang, L., Ullah, K., Ji, M., Jin, B., & Shu, J. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.982953 · Cited by 23
Pregnancy and Prenatal Management of Congenital Adrenal Hyperplasia
Cera, G., Locantore, P., Novizio, R., Maggio, E., Ramunno, V., Corsello, A., Policola, C., Concolino, P., Paragliola, R. M., & Pontecorvi, A. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11206156 · Cited by 27
“serum potassium should be used to titrate fludrocortisone doses instead of renin, which is unreliable during pregnancy [6,57,58].”
BackgroundChallenges Waiting for an Adult with DSD
Nowotny, H. F., & Reisch, N. (2022) · Hormone Research in Paediatrics · doi:10.1159/000527433 · Cited by 25
Diagnosis and management of classical congenital adrenal hyperplasia
Marumudi, E., Khadgawat, R., Surana, V., Shabir, I., Joseph, A. A., & Ammini, A. C. (2013) · Steroids · doi:10.1016/j.steroids.2013.04.007 · Cited by 23
“There are conflicting reports of fertility among women with CAH [45,46].”
Female fertility preservation in DSD
Kalra, R., Cameron, M. S., & Stern, C. J. (2019) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2019.101289 · Cited by 20
Burman, P., Falhammar, H., Waldenström, E., Sundin, A., & Bitzèn, U. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa870 · Cited by 19
Congenital Adrenal Hyperplasia: Do the Benefits of Prenatal Treatment Defeat the Risks?
Vos, A. A., & Bruinse, H. W. (2010) · Obstetrical & Gynecological Survey · doi:10.1097/ogx.0b013e3181d61046 · Cited by 22
Congenital Adrenal Hyperplasia
Speiser, P. (2015) · F1000Research · doi:10.12688/f1000research.6543.1 · Cited by 22
Components of Metabolic Syndrome in Youth With Classical Congenital Adrenal Hyperplasia
Kim, M. S., Fraga, N. R., Minaeian, N., & Geffner, M. E. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.848274 · Cited by 25
“Combined with emerging reports of type 2 diabetes, gestational diabetes, and adverse cardiac events in adults with classical CAH (20, 52, 53), further longitudinal study of this highrisk cohort is merited to assess risk factors from childhood through adulthood, to better understand the development of longer-term adver…”
BackgroundKudesia, R., Talib, H. J., & Pollack, S. E. (2016) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2016.07.004 · Cited by 20
Management aspects of congenital adrenal hyperplasia during adolescence and transition to adult care
Balagamage, C., Arshad, A., Elhassan, Y., Said, W. B., Krone, R. E., Gleeson, H. K., & Idkowiak, J. (2023) · Clinical Endocrinology · doi:10.1111/cen.14992 · Cited by 19
“113 Poor therapeutic control with excess production of adrenal androgens is a key factor exacerbating gonadal dysfunction by directly interfering with the hypothalamic – pituitary – ovarian axis.”
Kępczyńska‐Nyk, A., Kuryłowicz, A., Nowak, A., Bednarczuk, T., & Ambroziak, U. (2020) · Journal of Endocrinological Investigation · doi:10.1007/s40618-020-01332-3 · Cited by 17
Identity, sexuality, and parenthood in women with congenital adrenal hyperplasia
Engberg, H., Möller, A., Hagenfeldt, K., Nordenskjöld, A., & Frisén, L. (2020) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2020.05.005 · Cited by 15
Characteristics of In2G Variant in Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency
Kocova, M., Concolino, P., & Falhammar, H. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.788812 · Cited by 15
“Only approximately 25% of women with CAH conceive a child compared with 45% of matched controls (70, 71).”
BackgroundSelf-citationClinical outcomes in 21-hydroxylase deficiency
Nordenström, A., Lajić, S., & Falhammar, H. (2021) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000625 · Cited by 15
Molecular diagnosis of patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency
Reyes, T. M. E., Mesa, T. C., Cruz, P. A. L., Machado, A. A., Alonso, E. D., & Falhammar, H. (2020) · BMC Endocrine Disorders · doi:10.1186/s12902-020-00643-z · Cited by 15
Engberg, H., Nordenström, A., & Hirschberg, A. L. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae696 · Cited by 16
Ackerman, C. M., Lowe, L., Dyer, A. R., Hayes, M. G., Metzger, B. E., Lowe, W. L., Urbanek, M., & for the HAPO Study Cooperative Research Group (2013) · Hormone and Metabolic Research · doi:10.1055/s-0033-1347262 · Cited by 12
Concolino, P., & Falhammar, H. (2025) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaf018 · Cited by 12
“Mineralocorticoids, in the form of fludrocor-tisone, are particularly important prior to (since they may induce ovulation) and during pregnancy in patients with SW CAH but may also be used in those with SV CAH [16, 17].”
Self-citationHouben, C. H., Tsui, S. Y., Mou, J. W. C., Chan, K. W., Tam, Y., & Lee, K. H. (2014) · Hong Kong Medical Journal · doi:10.12809/hkmj144227 · Cited by 13
Congenital Adrenal Hyperplasia and Related Disorders
White, P. C. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0755-7.00570-4 · Cited by 11
Auer, M. K., Minea, C. E., Quinkler, M. O., Bancos, I., Beuschlein, F., Meyer, G., Lottspeich, C., Bidlingmaier, M., Rieger, E., Nowotny, H. F., et al. (2024) · Journal of the Endocrine Society · doi:10.1210/jendso/bvae211 · Cited by 14
“Previous studies have shown low fertility rates in CAH, but the general perception today is that those who wish to conceive, do conceive and pregnancy rates are equal to the general population [10, 23, 24].”
Fetal androgen excess provides a developmental origin for polycystic ovary syndrome
Abbott, D. H., & Dumesic, D. A. (2009) · Expert Review of Obstetrics & Gynecology · doi:10.1586/17474108.4.1.1 · Cited by 11
Seyam, R. M., Bissada, N., Abdul-Aaly, M., Sakati, N., Taweel, W. M. A., & Alkhudair, W. K. (2013) · Urology Annals · doi:10.4103/0974-7796.120308 · Cited by 12
“[20,21] One series reported three children born to two women out of 29 with SW.[8] In our study, however four of the married patients had SW , of whom two gave birth to healthy children compared to none in other studies.”
ResultDörr, H. G., Heß, J., Penger, T., Marx, M., & Oppelt, P. G. (2018) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-018-2091-8 · Cited by 13
“In women with classic CAH, the fertility rate is lower than in the general female population [13, 14], and an increased rate of miscarriages of 36% has been reported * Correspondence: helmuth-guenther.”
BackgroundCongenital adrenal hyperplasia in pregnancy: approach depends on who is the ‘patient’
Keely, E., & Malcolm, J. (2012) · Obstetric Medicine · doi:10.1258/om.2012.120015 · Cited by 11
Metadata
- Authors
- Hagenfeldt, K., Janson, P. O., Holmdahl, G., Falhammar, H., Filipsson, H., Frisen, L., Thoren, M., & Nordenskjold, A.
- Affiliations
- Karolinska University Hospital (SE)
- Sahlgrenska University Hospital (SE)
- Venue
- Human Reproduction
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-04-18
- Volume
- 23
- Issue
- 7
- Pages
- 1607-1613
- ISSN
- 0268-1161 (ISSN-L)
- 1460-2350
- OpenAlex
- W2120312421
- Cited by
- 205
- References
- 21
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 13 · 2023: 11 · 2022: 17 · 2021: 11 · 2020: 20 · 2019: 9 · 2018: 8 · 2017: 5 · 2016: 10 · 2015: 8 · 2014: 11 · 2013: 21 · 2012: 9
- FWCI
- 5.62
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Human Reproduction (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Keywords
- congenital adrenal hyperplasia, 21-hydroxylase deficiency, fertility, pregnancy outcomes, pregnancy rate, gestational diabetes mellitus, salt-wasting CAH, offspring sex ratio, child development, menopause, psychosocial factors, reproductive health
- MeSH terms
- Adolescent, Adrenal Hyperplasia, Congenital, Adult, Female, Fertility, Follow-Up Studies, Humans, Male, Menarche, Middle Aged, Pregnancy, Pregnancy Outcome, Sex Ratio, Steroid 21-Hydroxylase, Sweden, Diabetes, Gestational
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.